- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 35.86M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $19.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $25.15M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $36.6M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $44.88M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $149M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $103.06M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $196.03M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $159.48M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $43.36M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $104.6M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.71M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $903K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$9.36M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $156.89M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $165.49M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $8.21M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $3.29M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.92M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$7.61M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $3.89M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $3.54M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $7.42M |